Cargando…
Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
Lung cancer is one of the leading causes of cancer-related death. Lung cancer mortality has decreased over the past decade, which is partly attributed to improved treatments. Curative surgery for patients with early-stage lung cancer is the standard of care, but not all surgical treatments have a go...
Autores principales: | Peng, Yurong, Li, Zhuo, Fu, Yucheng, Pan, Yue, Zeng, Yue, Liu, Junqi, Xiao, Chaoyue, Zhang, Yingzhe, Su, Yahui, Li, Guoqing, Wu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905802/ https://www.ncbi.nlm.nih.gov/pubmed/36761954 http://dx.doi.org/10.3389/fonc.2023.1011810 |
Ejemplares similares
-
Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023) -
Tertiary Lymphoid Structures: A Potential Biomarker for Anti-Cancer Therapy
por: Zou, Ji’an, et al.
Publicado: (2022) -
Toxicities of Immunotherapy for Small Cell Lung Cancer
por: Fu, Yang, et al.
Publicado: (2021) -
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
por: Pan, Yue, et al.
Publicado: (2022) -
Perspectives on Immunotherapy of Metastatic Colorectal Cancer
por: Dai, Yongjiu, et al.
Publicado: (2021)